Dendritic Cell Status Modulates the Outcome of HIV-Related B Cell Disease Progression

1. MoirSFauciAS 2009 B cells in HIV infection and disease. Nat Rev Immunol 9 235 245

2. FontaineJChagon-ChoquetJValckeHSPoudrierJRogerM 2011 High expression levels of B Lymphocyte Stimulator (BLyS) by dendritic cells correlate with HIV-related B cell disease progression in humans. Blood 117 145 155

3. JacobsonMAKhayam-BashiHMartinJNBlackDNgV 2002 Effect of long-term highly antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr 31 472 477

4. CalabreseLHKirchnerEShresthaR 2005 Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 35 166 174

5. BekkerVScherpbierHPajkrtDJurriaansSZaaijerH 2006 Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 118 e315 e322

6. BatistaFDHarwoodNE 2009 The who, how and where of antigen presentation to B cells. Nat Rev Immunol 9 15 27

7. MacphersonGKushnirNWykesM 1999 Dendritic cells, B cells and the regulation of antibody synthesis. Immunol Rev 172 325 334

8. CeruttiARescignoM 2008 The biology of intestinal immunoglobulin A responses. Immunity 28 740 750

9. LekkerkerkerANvan KooykYGeijtenbeekTB 2006 Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 4 169 176

10. HannaZKayDGRebaiNGuimondAJothyS 1998 Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95 163 175

11. PoudrierJWengXKayDGParéGCalvoEL 2001 The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and auto-antibodies and develops in the absence of IFN-gamma and IL-6. Immunity 15 173 185

12. PoudrierJWengXKayDGHannaZJolicoeurP 2003 The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells. J Virol 77 11733 11744

13. MackayFFiggettWASaulepDLepageMHibbsML 2010 B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev 237 205 225

14. HässlerSRamseyCKarlssonMCLarssonDHerrmannB 2006 AIRE-deficient mice develop haematopoietic irregularities and marginal zone B-cell lymphoma. Blood 108 1941 1948

15. LindhELindSMLindmarkEHässlerSPerheentupaJ 2008 AIRE regulates T-cell-independent B-cell responses through BAFF. Proc Natl Acad Sci USA 105 18466 18471

16. FedericoMPercarioZOlivettaEFiorucciGMuratoriC 2001 HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 98 2752 2761

17. ManginoGPercarioZAFiorucciGVaccariGManriqueS 2007 In vitro treatment of human monocytes/macrophages with myristoylated recombinant NEF of human immunodeficiency virus type 1 leads to the activation of mitogen-activated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon. J Virol 81 2777 2791

18. QuarantaMGTritarelliEGiordaniLVioraM 2002 HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4 (+) T cell activation. Exp Cell Res 275 243 254

19. HeBQiaoXKlassePJChiuAChadburnA 2006 HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J Immunol 176 3931 3941

20. YuHLiuYHanJYangZShengW 2011 TLR7 regulates dendritic cell-dependent B cell responses through BLyS in immune thrombocytopenic purpura. Eur J Haematol 86 67 74

21. SabadoRLO'BrienMSubediAQinLHuN 2010 Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 116 3839 3852

22. FontaineJCoutléeFTremblayCRoutyJPPoudrierJ 2009 HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease. J Infect Dis 199 1007 1018

23. FontaineJPoudrierJRogerM 2011 Persistence of high blood levels of the chemokines CCL2, CCL19 and CCL20 during the course of HIV infection. AIDS Res Hum Retroviruses 27 655 657

24. del RioMLBernhardtGRodriguez-BarbosaJIFörsterR 2010 Development and functional specialization of CD103+ dendritic cells. Immunol Rev 234 268 281

25. WeillJCWellerSReynaudCA 2009 Human Marginal Zone B cells. Annu Rev Immunol 27 267 285

26. MalaspinaAMoirSChaittDGRehmCAKottililS 2007 Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 109 2086 2088

27. PantaleoGGraziosiCDemarestJFButiniLMontroniM 1993 HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362 355 358

28. VarinMMLe PottierLYouinouPSaulepDMackayF 2010 B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev 9 9 604 608

29. MalaspinaAMoirSHoJWangWHowellML 2006 Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A 103 2262 2267

30. CancroMPD'CruzDPKhamashtaMA 2009 The role of B Lymphocyte Stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest 119 5 1066 1073

31. CeruttiA 2008 The regulation of IgA class switching. Nat Rev Immunol 8 421 434

32. LesleyRXuYKalledSLHessDMSchwabSR 2004 Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20 441 453

33. ThienMPhanTGGardamSAmesburyMBastenA 2004 Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20 785 798

34. StohlWCheemaGSBriggsWSXuDSosnovtsevaS 2002 B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients. Clin Immunol 104 115 122

35. RodriguezBValdezHFreimuthWButlerTAsaadR 2003 Plasma levels of B-lymphocyte stimulator increase with HIV disease progression. AIDS 17 1983 2000

36. FagarasanSKawamotoSKanagawaOSuzukiK 2010 Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 28 243 273

37. ShacklettBL 2010 Immune responses to HIV and SIV in mucosal tissues: ‘location, location, location’. Curr Opin HIV AIDS 5 128 134

38. TudorDDerrienMDiomedeLDrilletASHouimelM 2009 HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Mucosal Immunol 2 412 426

39. BomselMTudorDDrilletASAlfsenAGanorY 2011 Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34 269 280

40. RescignoMDisabatinoA 2009 Dendritic cells in intestinal homeostasis and disease. J Clin Invest 119 2441 2450

41. XuWHeBChiuAChadburnAShanM 2007 Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nature Immunol 8 294 303

42. ManicassamySReizisBRavindranRNakayaHSalazar-GonzalezRM 2010 Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329 849 853

43. SodoraDLAllanJSApetreiCBrenchleyJMDouekDC 2009 Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15 861 865

44. LiQEstesJDSchlievertPMDuanLBrosnahanAJ 2009 Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 1034 1038

45. MandlJNBarryAPVanderfordTHKozyrNChavanR 2008 Divergent TLR7 and TLR9 signalling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infection. Nat Med 14 1077 1087

46. TezukaHAbeYAsanoJSatoTLiuJ 2011 Prominent Role for Plasmacytoid Dendritic Cells in Mucosal T Cell-Independent IgA Induction. Immunity 34 247 257

47. YangMSunLWangSKoKHXuH 2010 Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184 7 3321 3325

48. LundFERandallTD 2010 Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol 10 236 247

49. GrayDGrayM 2010 What are regulatory B cells? Eur J Immunol 40 2677 2679

50. MarinoEVillanuevaJWaltersSLiuwantaraDMackayF 2009 CD4+ CD25+ T cells control autoimmunity in the absence of B cells. Diabetes 58 1568 1577

51. Lai Kwan LamQKing Hung KoOZhengBJLuL 2008 Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 105 14993 14998